Clinical advances in periodontics · 2025
Risk for peri-implant diseases and defects: Report of workgroup 1 of the joint AO/AAP consensus conference on prevention and management of peri-implant diseases.
СтатьяConsensus StatementОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Kumar Purnima S, Kan Joseph, Galarraga-Vinueza Maria Elisa, Lin Guo-Hao, Monje Alberto, Tavelli Lorenzo, Stuhr Sandra, Hsu Yung-Ting, Li Junying, Tsigarida Alexandra, Dias Debora, Ganesan SukirthMurthy, Yin Shi, Curtis Don
Аннотация
BACKGROUND: A consensus meeting on peri-implant diseases and treatment was initiated by the American Academy of Periodontology (AAP) and the Academy of Osseointegration (AO) with the goal of developing subject- and site-level risk profiles for peri-implant diseases and defects, and risk-informed treatment recommendations. This report summarizes the conclusions of Working Group 1.
METHODS: Working Group 1 evaluated the risk for peri-implant diseases and defects based on four commissioned systematic reviews, followed by an in-person workshop to discuss the reviews and the inferences.
RESULTS: Several factors emerged as risk markers for peri-implant mucositis, peri-implantitis, as well as for soft and hard tissue discrepancies and defects in the absence of disease.
CONCLUSION: Patient- and site-level factors can increase the odds of developing peri-implant disease or defects in soft tissue and marginal bone surrounding clinically healthy implants. Risk-informed treatment recommendations were made by the panel of experts.
KEY POINTS: This consensus estimates risk based on both patient and site-level factors. Consideration must be given to modifiable and non-modifiable risk factors, and treatment modified accordingly. There is a lack of primary research on several topics that were considered by the consensus panel, and several gaps in knowledge still continue to exist.
METHODS: Working Group 1 evaluated the risk for peri-implant diseases and defects based on four commissioned systematic reviews, followed by an in-person workshop to discuss the reviews and the inferences.
RESULTS: Several factors emerged as risk markers for peri-implant mucositis, peri-implantitis, as well as for soft and hard tissue discrepancies and defects in the absence of disease.
CONCLUSION: Patient- and site-level factors can increase the odds of developing peri-implant disease or defects in soft tissue and marginal bone surrounding clinically healthy implants. Risk-informed treatment recommendations were made by the panel of experts.
KEY POINTS: This consensus estimates risk based on both patient and site-level factors. Consideration must be given to modifiable and non-modifiable risk factors, and treatment modified accordingly. There is a lack of primary research on several topics that were considered by the consensus panel, and several gaps in knowledge still continue to exist.